| Literature DB >> 29582571 |
Hong Chang Tan1, Tong Wei Yew2, Shaji Chacko3, E Shyong Tai2, Jean-Paul Kovalik4, Jianhong Ching4, Sandi Myo Thant2, Chin Meng Khoo2.
Abstract
AIMS/Entities:
Keywords: Endogenous glucose production; Non-obese Asian Indian; Skeletal muscle insulin sensitivity
Mesh:
Substances:
Year: 2018 PMID: 29582571 PMCID: PMC6215953 DOI: 10.1111/jdi.12844
Source DB: PubMed Journal: J Diabetes Investig ISSN: 2040-1116 Impact factor: 4.232
Baseline characteristics of Chinese and Indian men
| Chinese ( | Indian ( |
| |
|---|---|---|---|
| Age (years) | 26.9 ± 5.4 | 26.5 ± 4.2 | 0.809 |
| Systolic blood pressure (mmHg) | 122 ± 8 | 122 ± 9 | 0.384 |
| Diastolic blood pressure (mmHg) | 71 ± 9 | 71 ± 9 | 0.515 |
| Bodyweight (kg) | 69.0 ± 4.1 | 69.3 ± 6.3 | 0.91 |
| Fat mass (kg) | 15.5 ± 1.8 | 17.2 ± 5.5 | 0.303 |
| Fat free mass (kg) | 53.5 ± 4.4 | 52.0 ± 4.0 | 0.377 |
| Fat mass % | 22.5 ± 2.8 | 24.5 ± 6.3 | 0.303 |
| BMI (kg/m2) | 22.5 ± 1.1 | 23.0 ± 1.8 | 0.454 |
| HbA1c (%) | 5.3 ± 0.4 | 5.3 ± 0.4 | 0.963 |
| Fasting glucose (mg/dL) | 84.9 ± 4.6 | 83.1 ± 5,4 | 0.373 |
| Total cholesterol (mmol/L) | 5.0 ± 0.8 | 4.5 ± 0.6 | 0.112 |
| Triglyceride (mmol/L) | 1.0 ± 0.3 | 1.0 ± 0.5 | 0.941 |
| HDL cholesterol (mmol/L) | 1.4 ± 0.3 | 1.3 ± 0.3 | 0.336 |
| LDL cholesterol (mmol/L) | 3.2 ± 0.6 | 2.8 ± 0.5 | 0.139 |
| Alanine transaminase (U/L) | 23.9 ± 6.9 | 22.2 ± 9.1 | 0.605 |
| Aspratate aminotransferase (U/L) | 26.9 ± 7.6 | 24.3 ± 6.2 | 0.361 |
| Alkaline phosphatase (U/L) | 80.0 ± 19.4 | 72.9 ± 14.4 | 0.327 |
Data in mean ± standard deviation. BMI, body mass index; HbA1c, glycated hemoglobin; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein.
Hyperinsulinemic‐euglycemic clamp data in Chinese and Asian Indian men
| Chinese ( | Indian ( |
| |
|---|---|---|---|
| Free fatty acid (μmol/L) | |||
| Fasting | 197.4 ± 93.9 | 175.7 ± 60.8 | 0.491 |
| Clamp | 25.6 ± 13.4 | 29.3 ± 3.7 | 0.486 |
| Glucose (mg/dL) | |||
| Fasting | 83.4 ± 5.9 | 83.8 ± 4.0 | 0.856 |
| Clamp | 95.9 ± 5.0 | 99.7 ± 5.8 | 0.085 |
| Insulin (μU/mL) | |||
| Fasting | 7.48 ± 2.5 | 9.56 ± 3.2 | 0.079 |
| Clamp | 96.5 ± 17.0 | 111.7 ± 20.7 | 0.038 |
| Insulin metabolic clearance rate (mL/m2/min) | 458.1 ± 64.8 | 405.4 ± 78.8 | 0.075 |
| Glucose Rd (mg/kgFFM/min) | 10.4 ± 3.6 | 10.8 ± 2.7 | 0.77 |
| Rd/SSIns (mg/kgFFM/min per μU/mL) | 0.11 ± 0.04 | 0.10 ± 0.04 | 0.517 |
Data in mean ± standard deviation. FFM, fat free mass; Rd, glucose rate of disappearance during insulin clamp; SSIns, insulin concentration during insulin clamp steady state.
Figure 1Endogenous glucose production in Chinese and Indian men during fasting and insulin clamp steady‐state. Rates of endogneous glucose production (EGP) in Chinese and Indian men were measured and compared during fasting and insulin clamp steady‐state. No significant between‐group differences in EGP were detected in the fasted state, but EGP was completely and equally suppressed in response to insulin infusion. FFM, fat free mass.
Correlation between insulin metabolic clearance rate of Indian and Chinese men with various metabolic parameters
| Insulin MCR | ||
|---|---|---|
|
|
| |
| Weight | −0.364 | 0.067 |
| BMI | −0.378 | 0.057 |
| Fat mass | −0.418 | 0.034 |
| Fat mass (%) | −0.390 | 0.049 |
| Fasting glucose | 0.031 | 0.88 |
| Fasting insulin | −0.199 | 0.329 |
| HOMA‐IR | −0.259 | 0.201 |
| SSIns | −0.963 | <0.01 |
| Total cholesterol | 0.386 | 0.052 |
| HDL cholesterol | −0.052 | 0.838 |
| Triglycerides | 0.161 | 0.433 |
| LDL cholesterol | 0.442 | 0.024 |
| Fasting EGP | 0.410 | 0.037 |
| Alanine transaminase | −0.101 | −0.64 |
| Aspartate transaminase | −0.258 | 0.204 |
| Rd | 0.084 | 0.683 |
| Rd/SSIns | 0.524 | 0.006 |
BMI, body mass index; EGP, endogenous glucose production; HDL, high‐density lipoprotein; HOMA‐IR, homeostatic model assessment of insulin resistance; LDL, low‐density lipoprotein; MCR, metabolic clearance rate; Rd, rate of glucose disappearance; SSIns, insulin concentration during insulin clamp steady state.
Figure 2Respiratory quotient, plasma pyruvate and 3‐hydroxy‐butylrate in Indian and Chinese men during the fasted and insulin clamp steady‐state. (a) Respiratory quotient, (b) plasma pyruvate and (c) 3‐hydroxy‐butylrate (4‐OH) were measured in Chinese and Indian men in the fasted and insulin clamp steady‐state. All measured parameters responded significantly to insulin stimulation, but no significant interethnic differences were detected. Data presented as mean ± standard deviation.
Figure 3Plasma amino acids in Indian and Chinese men at the fasting and during insulin clamp steady‐state. (a) Essential and (b) non‐essential amino acids in Indian and Chinese men measured after an overnight fast and during insulin clamp steady state. All amino acids decreased significantly in response to insulin infusion. No significant interethnic differences were found in either the fasting or insulin‐stimulated state. *P < 0.05 of fasting vs insulin clamp.
Figure 4Acylcarnitine profiling in Indian and Chinese men during the fasting and insulin clamp steady‐state. (a) Plasma measurements of long, (b) intermediate, (c) short and (d) acetyl carnitines in the fasted and insulin clamp steady‐state. Insulin stimulation resulted in a statistically significant decrease in various acylcarnitines, but neither the fasting nor insulin clamp steady‐state values were different between ethnic groups. The acyl chain length, C, is denoted by the corresponding acyl chain length with C2 (acetyl carnitine), short‐chain (C3–C5), intermediate chain (C6–C12), long‐chain (C14–C18). *P < 0.05 of fasting vs insulin clamp. Data presented as mean ± standard deviation.